| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/03/2008 | CN101314000A Gastrodia tuber eucommia health care capsule and preparation method thereof |
| 12/03/2008 | CN101313994A Traditional Chinese medicine capsule for treating auricular fibrillation |
| 12/03/2008 | CN101313993A Compound red sage root effervescent tablet beverage |
| 12/03/2008 | CN101313989A Chinese medicinal composition for treating coronary disease, stenocardia |
| 12/03/2008 | CN101313988A Medicament for treating viral myocarditis |
| 12/03/2008 | CN101313985A Compound folium ginkgo capsule |
| 12/03/2008 | CN101313983A Compound garlic soft capsule |
| 12/03/2008 | CN101313982A Traditional Chinese medicine onion slurry, preparing method and uses thereof |
| 12/03/2008 | CN101313970A Medicament for treating hemorrhoids and use method |
| 12/03/2008 | CN101313968A Pseudo-ginseng dragon's blood preparation |
| 12/03/2008 | CN101313966A Medicament for treating asphyxia |
| 12/03/2008 | CN101313956A Compound chrysanthemum capsule |
| 12/03/2008 | CN101313954A Traditional Chinese medicine externally used effervescing agent (tablet) for pedicuring |
| 12/03/2008 | CN101313941A Compound antihyperglycemic pellet preparation and preparation method thereof |
| 12/03/2008 | CN101313940A Traditional Chinese medicine nourishing skin-protection plaster |
| 12/03/2008 | CN101313933A Externally used medicament for treating hemorrhoid |
| 12/03/2008 | CN101313927A Southernwood total flavone, method for preparing its composition and medicine uses thereof |
| 12/03/2008 | CN101313922A Method for obtaining extract from several frequently seen plants and uses of the extract |
| 12/03/2008 | CN101313918A Medicament composition dropping pills for curing angiocardiopathy and preparation method thereof |
| 12/03/2008 | CN101313917A Chinese medicine pill |
| 12/03/2008 | CN101313910A Preparation technique for sodium phosphocreatine freeze-dried injection |
| 12/03/2008 | CN101313907A Medicament composition for treating hyperpiesis |
| 12/03/2008 | CN101313906A Compound 2-benzyl-benzimidazole preparation of medicament for treating varicose vein of lower limb |
| 12/03/2008 | CN101313905A Composition containing telmisartan and preparing method thereof |
| 12/03/2008 | CN101313900A Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell |
| 12/03/2008 | CN101313873A Biology polypeptide medicament blood vessel bracket and preparation method thereof |
| 12/03/2008 | CN101313771A Solid beverage tablet of kudzu root containing gas and preparation technique |
| 12/03/2008 | CN100439493C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439397C Crystallization of IGF-1 |
| 12/03/2008 | CN100439393C Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 12/03/2008 | CN100439370C Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 12/03/2008 | CN100439366C Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors |
| 12/03/2008 | CN100439347C 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 12/03/2008 | CN100439345C (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 12/03/2008 | CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents |
| 12/03/2008 | CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 12/03/2008 | CN100439329C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 12/03/2008 | CN100438916C Transdermal formulation hydrogel substrate and its preparing method |
| 12/03/2008 | CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 12/03/2008 | CN100438909C 化合物 Compound |
| 12/03/2008 | CN100438872C Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 12/03/2008 | CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient |
| 12/03/2008 | CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 12/03/2008 | CN100438856C Yimaikang dispersion tablet and its preparing method |
| 12/02/2008 | US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 12/02/2008 | US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver |
| 12/02/2008 | US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 12/02/2008 | US7459465 Isoquinoline compound and pharmaceutical use thereof |
| 12/02/2008 | US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism |
| 12/02/2008 | US7459455 Pyrimidine compounds |
| 12/02/2008 | US7459438 sustained relese of saratin polypeptide to prevent platelet adhesion after vascular injury; thrombosis and restenosis inhibitor |
| 12/02/2008 | US7459436 Administering erythropoietin or derivative to treat diabetes |
| 12/02/2008 | US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety. |
| 12/02/2008 | US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot |
| 12/02/2008 | US7459142 High viscosity embolizing compositions comprising prepolymers |
| 12/02/2008 | CA2394230C Novel stromelysin inhibitors |
| 12/02/2008 | CA2361841C Mevinolin derivatives |
| 12/02/2008 | CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 12/02/2008 | CA2248300C Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them |
| 12/02/2008 | CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them |
| 12/02/2008 | CA2153604C Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields |
| 11/27/2008 | WO2008144754A2 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 11/27/2008 | WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 11/27/2008 | WO2008144268A1 Urotensin ii receptor antagonists |
| 11/27/2008 | WO2008143263A1 1-substituted tetrahydroisoquinoline compound |
| 11/27/2008 | WO2008143262A1 Heterocyclic compound and use thereof |
| 11/27/2008 | WO2008143182A1 Composition containing licorice-derived polyphenol |
| 11/27/2008 | WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 11/27/2008 | WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY |
| 11/27/2008 | WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same |
| 11/27/2008 | WO2008142106A1 Salts of picotamide |
| 11/27/2008 | WO2008141980A1 Substituted amino-thiourea compounds for combating animal pests |
| 11/27/2008 | WO2008141496A1 Sustained-release system for epo and gm-csf |
| 11/27/2008 | WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof |
| 11/27/2008 | WO2008141462A1 Novel case of renin inhibitors |
| 11/27/2008 | WO2008112651A3 Aminopyrimidines useful as inhibitors of protein kinases |
| 11/27/2008 | WO2008080037A3 Carotenoids of enhanced bioavailability |
| 11/27/2008 | WO2008061671A3 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 11/27/2008 | WO2008046087A3 Spiro compounds and their uses as therapeutic agents |
| 11/27/2008 | WO2008014219A3 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 11/27/2008 | US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof |
| 11/27/2008 | US20080293817 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 11/27/2008 | US20080293810 Multi-dose concentrate esmolol with benzyl alcohol |
| 11/27/2008 | US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents |
| 11/27/2008 | US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue |
| 11/27/2008 | US20080293791 Valsartan salts |
| 11/27/2008 | US20080293790 Substituted aryl oximes |
| 11/27/2008 | US20080293785 Substituted benzothiazole kinase inhibitors |
| 11/27/2008 | US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors |
| 11/27/2008 | US20080293781 Salicylic Acid Derivatives |
| 11/27/2008 | US20080293772 Salts of picotamide |
| 11/27/2008 | US20080293768 Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics |
| 11/27/2008 | US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity |
| 11/27/2008 | US20080293761 Pyrrolopyridine-2-Carboxylic Acid Amide Derivative Useful as Inhibitor of Glycogen Phosphorylase |
| 11/27/2008 | US20080293757 Abca1 elevating compounds |
| 11/27/2008 | US20080293750 Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment |
| 11/27/2008 | US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease |